A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

A new genetic study found a surprising link between instant coffee and age-related macular degeneration, which can’t be cured ...

Instant coffee has been linked to macular degeneration, which has no cure and progressively causes vision issues ...

Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsight’s analysis, the market for age-related macular degeneration is ...

Intravitreal anti-VEGF agents are linked to a slight increase in the risk for stroke in patients with age-related macular ...

Despite global anti-smoking efforts, high smoking rates persist in countries like Nauru and Myanmar due to cultural norms and economic factors. The US ...

Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system. Front Neurosci . 2022 Nov 3 ...

Epidemiology. Age-related macular degeneration (AMD) has a worldwide incidence of between 30 and 50 million people and is expected to affect up to 288 million people by the year 2040.